|
PSMD14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.603040E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.047950E-02 |
| Normal-vs-Stage2 |
6.218000E-01 |
| Normal-vs-Stage3 |
2.333200E-01 |
| Normal-vs-Stage4 |
1.160410E-01 |
| Stage1-vs-Stage2 |
2.829400E-01 |
| Stage1-vs-Stage3 |
5.408400E-01 |
| Stage1-vs-Stage4 |
4.419100E-03 |
| Stage2-vs-Stage3 |
6.742400E-01 |
| Stage2-vs-Stage4 |
9.795500E-02 |
| Stage3-vs-Stage4 |
2.998300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.398360E-01 |
| Normal-vs-AfricanAmerican |
7.080400E-01 |
| Normal-vs-Asian |
7.661600E-01 |
| Caucasian-vs-AfricanAmerican |
7.055800E-01 |
| Caucasian-vs-Asian |
6.442000E-01 |
| AfricanAmerican-vs-Asian |
7.663200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.498400E-02 |
| Normal-vs-Female |
6.827000E-01 |
| Male-vs-Female |
1.779900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.590000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.354000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.231370E-01 |
| Normal-vs-Age(81-100Yrs) |
6.302200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.637200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.566200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.063800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.317800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.201400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.662800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.292600E-01 |
| Normal-vs-Grade 2 |
1.508430E-02 |
| Normal-vs-Grade 3 |
1.221570E-01 |
| Normal-vs-Grade 4 |
2.250400E-02 |
| Grade 1-vs-Grade 2 |
7.478400E-01 |
| Grade 1-vs-Grade 3 |
5.451400E-01 |
| Grade 1-vs-Grade 4 |
6.705500E-02 |
| Grade 2-vs-Grade 3 |
4.183800E-01 |
| Grade 2-vs-Grade 4 |
4.009000E-04 |
| Grade 3-vs-Grade 4 |
2.104000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.643400E-04 |
| Normal-vs-ccB subtype |
6.838000E-01 |
| ccA subtype-vs-ccB subtype |
1.664620E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.028400E-01 |
| Normal-vs-N1 |
4.954100E-02 |
| N0-vs-N1 |
4.717600E-03 |
|
|
